Xencor, Inc. (XNCR)
24.94
+1.75
(+7.55%)
USD |
NASDAQ |
Oct 20, 16:00
25.19
+0.25
(+1.00%)
After-Hours: 07:09
Xencor Gross Profit (TTM) : 94.79M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.79M |
| March 31, 2026 | 86.96M |
| December 31, 2025 | 115.05M |
| September 30, 2025 | 139.19M |
| June 30, 2025 | 128.45M |
| March 31, 2025 | 101.43M |
| December 31, 2024 | 81.16M |
| September 30, 2024 | 72.82M |
| June 30, 2024 | 121.19M |
| March 31, 2024 | 149.89M |
| December 31, 2023 | 156.84M |
| September 30, 2023 | 134.83M |
| June 30, 2023 | 103.87M |
| March 31, 2023 | 89.18M |
| December 31, 2022 | 155.78M |
| September 30, 2022 | 288.24M |
| June 30, 2022 | 263.18M |
| March 31, 2022 | 235.22M |
| December 31, 2021 | 151.91M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 18.48M |
| December 31, 2019 | 18.48M |
| September 30, 2019 | 18.48M |
| June 30, 2019 | 18.48M |
| March 31, 2019 | -0.822M |
| December 31, 2018 | -1.552M |
| September 30, 2018 | -1.552M |
| June 30, 2018 | -1.552M |
| March 31, 2018 | -0.73M |
| December 31, 2017 | 3.09M |
| September 30, 2017 | 3.09M |
| June 30, 2017 | 3.09M |
| March 31, 2017 | 3.09M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 3.028M |
| March 31, 2014 | 3.028M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 387.48M |
| UroGen Pharma Ltd. | 171.46M |
| MeiraGTx Holdings Plc | 377.25M |
| IDEAYA Biosciences, Inc. | 229.62M |
| Iovance Biotherapeutics, Inc. | 120.66M |